| 000 | 01502 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250516095033.0 | ||
| 264 | 0 | _c20121226 | |
| 008 | 201212s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mds157 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFelip, E | |
| 245 | 0 | 0 |
_aDNA repair protein expression in resected NSCLC: a different predictive value for platinum benefit in adenocarcinoma versus squamous-cell carcinoma? _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cSep 2012 |
||
| 300 |
_a2211-2214 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDNA Repair |
| 650 | 0 | 4 |
_aDNA Repair Enzymes _xgenetics |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMartinez-Marti, A | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 23 _gno. 9 _gp. 2211-2214 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mds157 _zAvailable from publisher's website |
| 999 |
_c21852588 _d21852588 |
||